Frederick Locke, MD Program Co-Leader, Immunology, Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, regarding the clinical evidence supporting CAR-T cell therapies in multiple myeloma.
